Type III interferons (IFNs): Emerging Master Regulators of Immunity.

Area of Science:

• Immunology
• Virology
• Cytokine Biology

Background:

• Lambda interferons (IFN-λs), also known as type III interferons or interleukins 28 and 29, are a recent addition to the class II cytokine family.
• While sharing some functions with other interferons, IFN-λs possess unique activities that are not fully understood.
• Initially recognized for antiviral roles, IFN-λs are now known to influence antitumor and immune responses, particularly at mucosal surfaces.

Purpose of the Study:

• To review the diverse biological functions of IFN-λs.
• To examine the regulatory mechanisms governing IFN-λ expression.
• To explore the therapeutic potential of IFN-λs.

Main Methods:

• Literature review of existing research on IFN-λs.
• Analysis of studies on IFN-λs' expression, downstream effects, and roles in homeostasis and disease.
• Exploration of preclinical and clinical data regarding IFN-λ therapeutics.

Main Results:

• IFN-λs are critical for innate immunity in the gastrointestinal and respiratory tracts.
• These cytokines exhibit significant antiviral, antitumor, and immune-modulatory activities.
• Understanding IFN-λs' functions is key to their therapeutic application.

Conclusions:

• IFN-λs play a vital role in mucosal immunity and host defense.
• Their multifaceted functions suggest broad therapeutic applicability.
• Further research into IFN-λ biology will unlock novel treatment strategies.